Tigulixostat
Product Specifications
UNSPSC Description
Tigulixostat (LC350189) is an orally active, non-purine selective xanthine oxidase inhibitor. Tigulixostat lowers the production of uric acid. Tigulixostat can be used for gout and hyperuricemia study[1][2][3].
Target Antigen
Xanthine Oxidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/tigulixostat.html
Smiles
N#CC1=CN(C(C)C)C2=C1C=C(N3N=CC(C(O)=O)=C3)C=C2
Molecular Weight
294.31
References & Citations
[1]Seonghae Yoon, et al. Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects. Drug Des Devel Ther. 2015 Aug 31;9:5033-49. |[2]Li X, et al. Pharmacological urate-lowering approaches in chronic kidney disease. Eur J Med Chem. 2019 Mar 15;166:186-196.|[3]Terkeltaub R, et al. Serum Urate-Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Trial. Arthritis Rheumatol. 2023 Jul;75(7):1275-1284.
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139585/Tigulixostat-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139585/Tigulixostat-SDS-MedChemExpress.pdf
CAS Number
1287766-55-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1299631-01 0.02 mg (E-Coli)
Recombinant Rat Cell division cycle-associated 7-like protein (Cdca7l)
Ask
View Details MBS1299631-02 0.02 mg (Yeast)
Recombinant Rat Cell division cycle-associated 7-like protein (Cdca7l)
Ask
View Details 
MBS1299631-03 0.1 mg (E-Coli)
Recombinant Rat Cell division cycle-associated 7-like protein (Cdca7l)
Ask
View Details